mutations of IKBKB. These patients had normal B-cell and T-cell counts but very low levels of immunoglobulins, as well as a severe defect in immune-cell activation that affected both innate and adaptive immune-receptor pathways.
Me thods

Study Patients
The families of the four patients were from Manitoba and Saskatchewan in Canada and were of Northern Cree ancestry. No close family connection among these patients was known. The parents of each patient gave written informed consent. The University of Manitoba Health Research Ethics Board approved the study. The clinical characteristics of the patients are summarized in Table S1 in the Supplementary Appendix, available with the full text of this article at NEJM.org.
Patient 1 (from Family 1) became ill at 1 month of age with oral candidiasis and feeding difficulties. At 4 months of age, she had Escherichia coli septicemia, parainfluenza virus type 1 pneumonia, and persistent oral candidiasis. Laboratory testing showed hypogammaglobulinemia (Table S1 in the Supplementary Appendix), and SCID was diagnosed clinically. Her condition was stabilized with antimicrobial agents and intravenous immune globulin. She received a cord-blood transplant after reduced-intensity conditioning, but the graft was rejected. She had two episodes of pneumococcal bacteremia associated with osteomyelitis, from which she recovered, but she died from Mycobacterium avium sepsis. There was no family history of immunodeficiency or death in early infancy.
Patient 2 (from Family 2) first presented at 6 weeks of age, when she required ventilator assistance because of upper-airway obstruction caused by severe oropharyngeal candidiasis. She had reduced IgM levels; detectable IgG was probably of maternal origin (Table S1 in the Supplementary Appendix). Bacterial septicemia developed, and her neurologic condition deteriorated rapidly; analysis of the cerebrospinal fluid revealed Listeria monocytogenes. A computed tomographic (CT) scan of the head showed hemorrhages in the posterior fossa, frontal subdural effusions, and bilateral middle-cerebral-artery infarction. She died from this infection 2.5 months after birth. Autopsy revealed a small spleen and thymus and no lymph nodes in the neck or mesentery. Microscopic examination showed small periarterial lymphoid aggregates, which were devoid of germinal centers, in the spleen; plasmacytoid cells were not noted. A scant lymphoid population was found in the thymus, largely located in the medulla; Hassall's corpuscles were present, and there were numerous histiocytes in the cortex. The patient had one healthy sibling and no family history of immunodeficiency.
Patient 3 (from Family 3) was hospitalized at 5 months of age with pneumonia, from which he recovered. Oral candidiasis subsequently developed. He was readmitted at 6 months of age with parainfluenza virus type 3 pneumonia, chronic diarrhea, and poor weight gain (Table S1 in the Supplementary Appendix). After myeloablative conditioning, he received a bone marrow transplant from his human leukocyte antigenidentical sister. After initial engraftment (97% donor CD3+ cells), mixed chimerism with 50% donor CD3+ cells developed; his condition has remained stable over a period of more than 24 months. After tuberculosis was diagnosed in his grandfather, the child's gastric washings were found to be positive for acid-fast bacilli; he started receiving antituberculosis therapy and has remained clinically well. His three older siblings were healthy; a fourth sibling died at 14 months of age as a result of chronic infections.
Patient 4 (from Family 4) presented at 3 months of age with oral and genitourinary candidiasis. Three months later, Serratia marcescens bacteremia with pancytopenia developed. She had agammaglobulinemia (Table S1 in the Supplementary Appendix) and was given intravenous immune globulin. At 6 months of age, focal seizures developed. Magnetic resonance imaging suggested the presence of infarcts in both hemispheres of the brain. Eye deviation developed; CT scanning showed a right frontal infarct, a deep thalamic hemorrhage, and large subdural collections that were consistent with abscess formation and hemorrhage. Four weeks later, blood cultures were positive for E. coli, klebsiella, and serratia. The bacteremia resolved after surgical drainage of the subdural abscess. At 8 months of age, she received an unrelated-donor cord-blood transplant after myeloablative conditioning. She had slow T-cell engraftment. Four months after transplantation, she had mixed chimerism with 85% donor CD3+ cells. She has remained clinically well except for neurologic sequelae.
Genetic and Other Analyses
The methods for immunologic phenotyping, genetic and protein analyses, and functional investigations are described in detail in the Supplementary Appendix.
R esult s
Basic Immunologic Phenotype
All four patients had hypogammaglobulinemia or agammaglobulinemia but normal T-cell counts in the absence of maternal engraftment. One patient had slightly reduced B-cell counts, and three patients had reduced natural killer (NK) cell counts. The patients' immunophenotypes at presentation are summarized in Table S1 in the Supplementary Appendix.
Autosomal Recessive IKBKB Mutation
To elucidate the molecular basis of this unusual immunodeficiency, we assumed autosomal recessive inheritance of a founder allele and conducted homozygosity mapping in four patients and three healthy siblings (Fig. 1A) . Overlapping homozygosity was found in only one candidate region, spanning 11.6 Mbp on chromosome 8 (Fig. 1B) . All 40 genes within this region were sequenced with the use of genomic DNA or complementary DNA. The only biallelic mutation identified in all four patients was a homozygous duplication, c.1292dupG in exon 13 of the IKBKB gene (Fig. 1C) . No other potentially diseasecausing mutations were detected. Genotyping of healthy family members revealed carriers of this mutation but no other homozygotes (Fig. 1A) . The mutation is not listed in dbSNP (www.ncbi.nlm .nih.gov/projects/SNP) or in the 1000 Genomes database (www.1000genomes.org). This frameshift mutation leads to a premature stop codon and results in a complete loss of IKK2 protein in fibroblasts and peripheral-blood mononuclear cells (Fig. 1D, 1E , and 1F). Western blot analysis and immunoprecipitation after stimulation with TNF-α or mitogen phorbol 12-myristate 13-acetate (PMA) revealed reduced amounts of NEMO and IKK1 despite normal messenger RNA (mRNA) levels ( Fig. 1E and 1F , and Fig. S1 and S7C in the Supplementary Appendix), which suggested that the lack of IKK2 affects the stability of other members of the IKK complex. To determine whether the IKBKB mutation is restricted to patients of Northern Cree ancestry, we sequenced the IKBKB gene in six white patients with a simi- 
-
C o n t r o l C o n t r o l P a t i e n t C o n t r o l P a t i e n t C o n t r o l P a t i e n t P a t i e n t C o n t r o l P a t i e n t Panel A shows the pedigrees of four families of Northern Cree ancestry with immunodeficient children (Patients 1, 2, 3, and 4). Squares denote male family members, circles female members, and slashes deceased family members. The four patients (solid arrows) and three healthy siblings (open arrows) were included in homozygosity mapping analysis. Solid symbols denote family members who were homozygous for the IKBKB mutation, half-solid symbols members who were heterozygous for the mutation, and open symbols members who did not have the mutation; family members not tested genetically are indicated by question marks. Panel B shows the candidate interval on chromosome 8 (NCBI36, hg18 assembly) encompassing the mutated gene. Delimiting single-nucleotide polymorphisms are indicated. The region spans 40 genes, including IKBKB at p11.21. Panel C depicts the IKBKB sequence analysis in one patient as compared with that in a healthy control; the sequence has a homozygous G duplication in exon 13, leading to a frameshift at the protein level, starting at amino acid 432. Panel D shows the predicted loss of most of the α-helical scaffold dimerization domain encompassing the leucine-zipper (LZ) and helix-loop-helix (HLH) domains and the nuclear factor κB (NF-κB) essential modulator (NEMO)-binding domain (NBD) of IκB kinase 2 (IKK2), with no effects on the kinase domain or the ubiquitin-like domain (amino acids 307 to 384). Panel E shows the Western blot analysis of primary fibroblast-derived protein from Patient 1, which had a complete lack of the IKK2 protein. Amounts of IκB kinase 1 (IKK1), NEMO, and p65 are reduced as compared with control fibroblasts that were untreated or stimulated with TNF-α or phorbol 12-myristate 13-acetate (PMA). β-Actin served as a loading control. Panel lar immunophenotype. No mutations in IKBKB were identified in these patients.
Impaired NF-κB Signaling
Many receptors involved in innate and adaptive immunity, including antigen receptors, TLRs, and inflammatory cytokine receptors, signal by means of the canonical NF-κB pathway, of which IKK2 is a central component. IKK2-deficient patient fibroblasts showed impaired phosphorylation of IκBα in response to TNF-α stimulation ( Fig. 2A) . Degradation of IκBα after interleukin-1β stimulation was marginally affected, whereas degradation in response to TLR5 stimulation by flagellin was absent, indicating distinct requirements for IKK2 (Fig. S2 in the Supplementary Appendix). The reduced but not absent effect of interleukin-1β on IκBα degradation mirrors observations in previous studies of fibroblasts with prominent NEMO reduction. 16 We found that NF-κB binding to DNA after TNF-α stimulation was considerably decreased in patient cells but that the NF-κB heterodimer composition (p50-p65) was similar to that in control cells. Similar results were obtained for PMA stimulation ( has been reported. 17 We analyzed NF-κB-mediated gene expression in fibroblasts from the patients. Interleukin-6 production in response to TNF-α or interleukin-1β was normal, whereas it was reduced in response to lipopolysaccharide (which acts through TLR4) or flagellin, suggesting that interleukin-6 production is variably dependent on IKK2 (Fig. 2D) . In NF-κB/AP-1-dependent luciferase reporter assays, responses to TNF-α, interleukin-1β, lipopolysaccharide, and flagellin were reduced in IKK2-deficient fibroblasts, as compared with control transfectants, whereas the response to polyinosinic-polycytidylic acid (through TLR3) was not reduced (Fig. S5 in the Supplementary Appendix). The varying responses to TNF-α and interleukin-1β may reflect differences in promoter availability, in the number of NF-κB binding sites, or in co-transcription factor dependence in the particular assays.
Similar results in studies of protein stability, NF-κB-binding activity induced by TNF-α and PMA, and IκBα phosphorylation were obtained with human IKK2 knockdown fibroblasts (Fig. S6 in the Supplementary Appendix). Interleukin-6 production triggered by interleukin-1β was not affected in IKK2 knockdown cells (data not shown). Panel A shows IKK complex activity in primary skin fibroblasts. IKK complex activity was measured before and after treatment for 15 minutes with tumor necrosis factor α (TNF-α; final concentration, 50 ng per milliliter), with the use of anti-NEMO-specific immunoprecipitated IKK complexes of whole-cell lysates (0.5 mg of protein). IKK activity was determined with glutathione S-transferase (GST)-IκBα as a substrate. Basal and TNF-α-induced IKK activity is dramatically reduced in cells from the patient. Panel B shows NF-κB activity in primary skin fibroblasts, measured with the use of an electrophoretic mobility shift assay (EMSA) for NF-κB and specificity protein 1 (SP1). Whole-cell lysates (10 μg) were isolated from untreated cells, cells treated with TNF-α for 15 minutes (final concentration, 50 ng per milliliter), and cells treated with PMA for 30 minutes (final concentration, 100 ng per milliliter). NF-κB indicates NF-κB-specific DNA binding. NF-κB activation by TNF-α is reduced to a great extent but still present in cells from the patient; basal and PMA-induced NF-κB activity is almost absent. SP1 DNA binding served as a quality control. NS denotes nonspecific band. Panel C shows NF-κB activation reconstituted in primary cells from the patient on reexpression of IKK2. The patient's cells were transiently transfected with either an IKK2 expression vector or empty vector (Vec). After 48 hours, transfected and nontransfected cells were stimulated with TNF-α for 15 minutes (final concentration, 50 ng per milliliter), and whole-cell lysates were evaluated with the use of EMSA (for NF-κB and SP1) and Western blot analysis (for IKK2, NEMO, and ERK2). NF-κB indicates NF-κB-specific DNA binding. Normal levels of NF-κB activation by TNF-α were restored in cells from the patient that reexpressed Quantitative reverse-transcriptase-polymerasechain-reaction analyses of NF-κB target genes showed similar or only slightly reduced CCL2, ICAM1, NFKB2, RELB, TNF, TNFAIP3, and VIM mRNA levels in stimulated IKK2-deficient fibroblasts, whereas levels of other RNAs -most notably, certain chemokine mRNAs -were markedly lower in response to TNF-α stimulation (BCL2A1, CCL5, CXCL3, CXCL10, TRAF1, and C3) or PMA stimulation (CXCL10, TRAF1, and MMP9) ( To exclude the possibility that the reduced cellular responses were caused by inadequate receptor expression, we measured levels of mRNA encoding the two TNF receptors, the interleukin-1 receptor chains (interleukin-1R1 and interleukin-1RAP), and TLR4 and TLR5, all of which were normal ( Fig. S7B in the Supplementary Appendix). Moreover, impaired NF-κB signaling was not due to low NEMO or IKK1 mRNA levels. In contrast, IKK2 mRNA levels were significantly decreased, possibly reflecting reduced mRNA stability due to nonsense-mediated decay (Fig. S7C in the Supplementary Appendix).
Lymphocyte Differentiation and Activation Defect
To address the question of whether IKK2 deficiency affects T-cell development, we measured T-cell-receptor excision circle (TREC) levels in C o n t r o l P a t i e n t C o n t r o l P a t i e n t
TNF-α Untreated
C o n t r o l P a t i e n t C o n t r o l P a t i e n t PMA C o n t r o l P a t i e n t two patients with the use of the dried blood spots from original Guthrie cards used to screen for congenital defects in newborns. TRECs are small pieces of DNA excised from newly produced T cells during the rearrangement of their receptor genes, and TREC levels are a measure of T-cell production. Both patients had normal TREC levels (Table S1 and Even when patients had a history of serious infection, 93% of their CD4+ T cells expressed CD45RA, and 85% of these cells expressed CD27 (data not shown); CD45RA and CD27 are markers of antigen-naive T cells. In addition, CD8+ T cells in these patients were almost exclusively naive (CD45RA+CCR7+), whereas more differentiated CD8+ T cells were readily detectable in agematched controls (Fig. S9C in the Supplementary Appendix). 18, 19 CD25 high FOXP3+CD4+ regulatory T cells were almost absent in the two patients (Fig. S9D in the Supplementary Appendix). On stimulation with anti-CD3 and anti-CD28 antibodies, up-regulation of the T-cell activation markers CD25 and CD69 was reduced but detectable (Fig. 3A) . Proliferation responses were assessed with the use of different techniques (Fig. 3B , and Fig. S9E in the Supplementary Appendix). Phytohemagglutinin mitogenic responses were moderately reduced, and there was little response to soluble or plate-bound anti-CD3 antibodies. However, stimulation with anti-CD3 and anti-CD28 antibody beads produced a surprisingly strong response that was only mildly reduced as compared with the control response. Consistent with this observation was our finding that the proportion of patient T cells producing interleukin-2 in response to stimulation with PMA and ionomycin was similar to that in cells from agematched controls, whereas interferon-γ production was relatively low (Fig. 3C) .
GST-
Stimulation with the erythroleukemia cell line K562 did not induce CD107a degranulation of NK cells from the patients (Fig. S10A in the Supplementary Appendix), an observation that is compatible with the requirement of NF-κB activation for NK-cell cytotoxicity. Moreover, stimulation with K562 induced chemokine (C-C motif) ligand 4 (CCL4) expression but did not elicit interferon-γ production (Fig. S10B in the Supplementary Appendix).
B-cell development in two patients, assessed as levels of kappa-deleting recombination excision circles (KRECs, indicating production of new B cells) in dried blood spots from Guthrie cards, was within the range of values in controls (Table S1 and Fig. S8 in the Supplementary Appendix). B cells were almost exclusively naive, with a normal proportion of transitional cells (CD38+IGM+) and a lack of class-switched memory B cells (CD27+IGD−) and plasmablasts (CD38+CD20−) (Fig. S11A in the Supplementary Appendix), which were present in age-matched controls. 18, 19 Germinal-center B-cell activation is dependent on costimulatory signals and cytokines such as CD40L and interleukin-21, provided by follicular helper T cells. 20, 21 In line with the defect observed in peripheral blood from our patients, their B cells did not differentiate into plasmablasts when stimulated with CD40L and interleukin-21, whereas cord-blood B cells, similarly composed of transitional and naive B cells, generated 5 to 10% CD27 high CD38 high plasmablast cells after 9 days of cultivation (Fig. 3D) . In B cells, proliferation is required for differentiation. 22 B cells from our patients did not proliferate in response to CD40L and interleukin-21 (Fig. S11B in the Supplementary Appendix), because they did not up-regulate interleukin-21 receptor in response to CD40L stimulation (Fig. S11C in the Supplementary Appendix). In contrast, proliferation was observed in the B cells when they were stimulated by means of the B-cell antigen receptor and TLR9. For TLR9 stimulation, CpG, a cytosine-guanine dinucleotide polymer, was used (Fig. S11B in the Supplementary Appendix) . B cells from the patients produced no immunoglobulins on stimulation with CD40L and interleukin-21 or anti-IgM antibody and CpG (Fig. S11D in the Supplementary Appendix). Furthermore, activation markers correlating with B-cell function, such as CD69 (location in the germinal center), CD95 (selection in the germinal center), and CD86 (antigen presentation), were differentially expressed on activation in one of the patients, as compared with a control (Fig. S11E in the Supplementary Appendix).
Discussion
In this study, we examined four immunodeficient infants with an autosomal recessive IKBKB mutation resulting in a complete loss of IKK2 protein expression. All patients presented with early-onset, life-threatening bacterial, fungal, and viral infections and failure to thrive, conditions that are consistent with a clinical diagnosis of SCID.
Our immunologic and functional investigations revealed that IKK2 is mostly expendable for the development of B and T lymphocytes but is necessary for the differentiation of regulatory and γδ T cells and possibly also NK cells. A lack of memory and regulatory T cells has been reported in conditional mouse models of Ikk2 deficiency, but the absence of γδ T cells was not anticipated from these studies. 23, 24 The observation that γδ T cells are absent in humans with autosomal dominant mutations in IκBα corroborates our findings. 12 Impairment of intrathymic lymphotoxin β receptor and CD27-mediated activation of NF-κB during the development of γδ T cells may account for their absence. 25 It is notable that in Ikk2 conditional knockout mice in which Ikk2 was deleted only in B cells, the relative frequency of B cells was significantly reduced in peripheral blood. 26, 27 IKK2 is indispensable for transmitting signals by various surface receptors. Thus, the activation of T, B, and NK cells in our patients was significantly reduced, which accounted for the defective immunoglobulin production. The residual proliferative and cytokine response of T cells was higher than expected for infants with such a severe and early clinical presentation. Moreover, although all four patients had severe oral candidiasis compatible with a T-cell deficiency, characteristic pneumocystis infections were not observed in our four patients. Our finding of an impaired response to TNF-α, as well as to TLR4 or TLR5 stimulation, indicates an additional innate immunologic defect in these patients. In fact, bacterial sepsis and mycobacterial infection are seen in patients with hypomorphic mutations in IKBKG, the X-linked gene encoding NEMO. 10 Although the clinical presentation in the context of the B-cell and T-cell defects justifies the classification of IKK2 deficiency as SCID, it is likely that the innate immunologic defect contributes substantially to the severity of the phenotype. Overall, our findings suggest that IKK2 deficiency, in addition to deficiencies in ORAI1 (a calcium-channel protein) and STIM1 (a stromal interaction molecule that is a calcium sensor), is a molecular cause of SCID characterized by a normal number of T cells that fail to be activated. 2 Mutations in genes encoding the two other components of the human IKK complex have been described. Mutations in CHUK, encoding IKK1, result in the autosomal-recessive lethal cocoon syndrome, characterized by fetal encasement and multiple malformations. 28 These developmental defects were absent in our patients. The immunologic phenotypes of patients with NEMO deficiency are accompanied in about 90% of cases by anhidrotic ectodermal dysplasia and occasionally by osteopetrosis and lymphedema.
Patients with IκBα mutations always have anhidrotic ectodermal dysplasia. 10 In contrast, we have not observed any of the developmental symptoms associated with deficiencies in IKK1, NEMO, and IκBα in our IKK2-deficient patients. An impaired NEMO-IKK2 axis is therefore not the cause of these nonimmunologic symptoms of NEMO deficiency, suggesting that ectodysplasin A-receptor signaling may not depend on IKK2.
In contrast to the effects we observed in humans, a complete Ikbkb knockout in mice causes embryonic death at approximately day 13 as a 2513 result of extensive TNF-α-triggered apoptotic liver damage. 29, 30 Ikk2 −/− mice can be rescued by inactivation of the TNF receptor 1 gene. In our patients, results of sequence and expression analyses of TNF-α and TNF receptor chain genes were normal, except for a heterozygous TNFRSF1B mutation (p.Arg41Pro) in Patient 1 (data not shown). This suggests that the survival of IKK2-deficient patients is independent of a disruption of the TNF-α-TNF receptor signaling pathway. Severe liver damage was not present in our patients.
Canonical IKK2-NF-κB signaling plays a crucial role in the regulation of inflammation and oncogenesis. In the past, efforts have been made to detect and develop IKK2 inhibitors for therapeutic purposes. 31, 32 The fact that complete Ikk2 deficiency is lethal in mouse embryos challenged this strategy. The cases of immunodeficiency that we describe suggest that a complete loss of IKK2 is not lethal in all humans. However, on the basis of these cases, it remains possible that the consequences of IKK2 inhibition would be severe. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
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Supplementary Methods
Genomic DNA preparation
Genomic DNA was prepared using the QIAmp DNA Blood Kit (QIAGEN, Hilden, Germany).
RNA isolation and RT-PCR
RNA was isolated using the RNeasy Mini Kit (QIAGEN) followed by DNAse digestion. 
SNP analysis and homozygosity mapping
Genotyping was performed on the Affymetrix GeneChip platform (Affymetrix, Santa Clara, USA) using the Genome-Wide Human SNP Array 6.0, containing 906,600 single nucleotide polymorphisms (SNPs). We subjected 500 ng of DNA to restriction endonuclease digestion and processed the products according to the manufacturer's instructions. Arrays were hybridized, stained, washed and scanned using a Hybridization Oven 640, Fluidics station FS450 and a GeneChip Scanner 3000 7G according to the instructions of the manufacturer. After generation of the raw data (CELfiles) using Command Console software (Affymetrix) SNP genotype calls were generated by applying the birdseed algorithm V2 in Genotyping Console software Immunoprecipitates were separated by SDS/PAGE and blotted on a PVDF membrane, which was exposed to films to detect radioactivity.
Degradation of IB
Immortalized skin fibroblasts were grown to 70% confluence and seeded into 6-well dishes at a density of 5 x 10 5 per well using VLE RPMI 1640 medium (Biochrom AG, 
EMSA and Supershift Assay
We performed electromobility shift and supershift assays as previously described. Thereby activated NF-B can be determined (activity of firefly luciferase) and normalized to transfection efficiency (activity of Renilla luciferase). The following day, cells were stimulated for 6 h as indicated and lysed in reporter lysis buffer (Promega).
Luciferase activity was measured with a plate-reader luminometer (Berthold, Bad
Wildbad, Germany).
Flow cytometry
The antibodies used for flow cytometry are listed in Supplementary Table 1 .
Regulatory T cells were stained using the Human Regulatory T cell Staining Kit (ebioscience, Affymetrix, Santa Clara, USA). Data acquisition was performed with a Gallios Flow cytometer (Beckman Coulter, Brea, USA) or FACS Canto (BD Biosciences, San Jose, USA). Data were analyzed using FlowJo version 7.2.5
analysis software (Tree Star, Ashland, USA).
Functional analysis of T cells
Early T cell activation: 
TREC and KREC analyses
Regular dried neonatal blood spot samples (Guthrie cards) from the included patients
were analyzed in the combined TREC-KREC assay as described before. 37 The qPCR procedure was optimized based on custom reagents provided by Affymetrix, and the cut off range was modified according to current prospective trials in Germany and Sweden. Previously reported SCID patients with IL2RG or RAG1 mutations, as well as newborn samples from XLA patients with BTK mutations were included as reference controls. 
ELISA of B cell supernatants
Immunoglobulin secretion was measured by ELISA in culture supernatant at day 6 of indicated stimulation as described. 40 In brief, 96-well plates (Maxisorp; Nunc, Naperville, Ill) were coated with anti-human immunoglobulin mix (Jackson Immortalized skin fibroblasts were transfected with an ELAM.luciferase reporter construct (firefly luciferase) plus a constitutive CMV.luciferase construct (Renilla luciferase, for normalization of transfection) as outlined in the methods section. 24 h after transfection, the cells were stimulated for 5 hours with the indicated agents TNF (30 ng/mL), IL1 (5 ng/mL), LPS (10 g/mL), flagellin (2.5 g/mL), or poly I:C (50 g/mL) for 16 h. Cells were lysed and luminescence was measured. Depicted is the induction of the ratio between firefly and Renilla luciferase readings of stimulated as compared to control (medium) samples (x-fold). Data points represent means of duplicates in a representative experiment out of four. Gene specific primers and hydrolysis probes were designed by the Roche Universal Probe Library system. NEMO (1) and NEMO (2) indicate two independent primer and probe sets. Relative gene expression is shown using RPL13 as reference gene for relative quantification. Mean +/-SD; n = 3 biological replicates, qRT-PCR was performed in duplicates. All p-values are derived from a Student's unpaired, two-tailed t test. *p<0.05; **p<0.01; ***p<0.001. 
